Goldman Sachs Upgrades Passage Bio Inc. (PASG) to Buy

Goldman Sachs analyst Salveen Richter upgraded Passage Bio Inc. (NASDAQ: PASG) from Neutral to Buy with a price target of $30.00 (from $28.00).

For an analyst ratings summary and ratings history on Passage Bio Inc. click here. For more ratings news on Passage Bio Inc. click here.

Shares of Passage Bio Inc. closed at $19.96 yesterday.

You May Also Be Interested In

• Nomura/Instinet Upgrades Wipro Ltd. (WPRO:IN) (WIT) to Neutral
• ERO Copper (ERO:CN) (ERRPF) PT Raised to Cdn$27.50 at Canaccord Genuity
• Cia Brasileira de Distribuicao (PCAR3:BZ) PT Raised to R$39 at Morgan Stanley